RAG-17 therapy slowed functional decline and stabilized or improved breathing in people with ALS who carry mutations in the SOD1 gene.

Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). Some 4,000 Canadians are currently living with the disease. There are few ...

When actor Eric Dane recently announced his diagnosis of ALS, it once again put this horrible disease in the spotlight.

The following is a summary of “Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis,” published in the April 2025 issue of Journal of ...

Eric Dane's ALS diagnosis has raised awareness about Lou Gehrig's disease, its symptoms, causes, and how other celebrities ...

The company expects early cohort data this year from the trial assessing the calpain-2-targeted antisense oligonucleotide therapy.

Eric Dane revealed he's been diagnosed with amyotrophic lateral sclerosis, also known as ALS. Here's what to know about the rare disease.

PrimeC has demonstrated promising results in the 18-month Phase 2b trial, with data highlighting its potential as a disease-modifying therapy for ALS. The trial revealed a marked reduction in ALS ...

Verge Genomics will use digital biomarkers to assess short-term disease progression in an ALS trial testing its VRG50635 ...

The trial will explore the ALS biomarkers, including the change from baseline in levels of neurofilament light chain.